University of Michigan at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
University of Michigan brings 7 presentations to AMP 2026 in Seattle. Its sessions centre on spatial and transcriptomic profiling, targeted treatment of acute myeloid leukaemia, and new ways to read structure in cancer genomes. Its optical genome mapping work reports seven months of clinical experience in standard care of acute leukaemias.
| Organization | AMP 2026 Attendance |
|---|---|
University of Michigan Ann Arbor, MI | |
Public research university and academic medical centre in Ann Arbor with clinical cancer genomics and molecular diagnostics programmes. | Session Thu, Nov 12 10:15am–11:45am Clinical Applications of Transcriptomics in Lymphomas and Leukemias
Session Thu, Nov 12 10:15am–11:45am Technical Advancement in Spatial Genomics and Multi-omics
Talk Thu, Nov 12 11:00am–11:45am Molecular-Resolution Spatial Inference of Subcellular Transcriptional Programs Submicron spatial transcriptomics plus segmentation-free analysis that assigns cell type and transcriptional programs from individual transcripts. Workshop Thu, Nov 12 12:40pm–1:10pm AI in Trainee Education: A Demonstration and Discussion Building a large language model study aid for pathology trainees, alongside survey findings on how trainees and educators use AI. Talk Thu, Nov 12 8:30am–8:45am Opening Remarks
Talk Fri, Nov 13 2:00pm–2:45pm Development and Use of Menin Inhibitors as Precision Medicines for Acute Myeloid Leukemia Development of menin inhibitors for KMT2A-rearranged and NPM1-mutant acute myeloid leukemia, plus response biomarkers and resistance. Poster Fri, Nov 13 7:15am–7:30am |
Instantly find 20 buyers from University of Michigan
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction